Medicine News and Research

RSS

New findings offer insights into novel treatment avenue for Crohn's Disease, sarcoidosis

A new finding out in the December 1st issue of Genes & Development offers insight into a new treatment avenue for two painful inflammatory diseases: Crohn's Disease and sarcoidosis.

30 Nov 2010

Golimumab with methotrexate improves markers of inflammation and structural damage in RA patients

Magnetic resonance imaging (MRI) analyses from two Phase 3 clinical trials showed that once every four week subcutaneous injections of golimumab 50 mg plus methotrexate resulted in statistically significant improvements in markers of inflammation and structural damage in patients with active rheumatoid arthritis (RA) compared with placebo plus methotrexate.

30 Nov 2010

Celulas Genetica licenses new organ regeneration treatment from Chinese BBFITCL

Emerging Healthcare Solutions, Inc. announced today that its affiliate, Celulas Genetica, purchased a license to develop and market a revolutionary new medical treatment known as the Rutherford Procedure.

30 Nov 2010

Scientists identify signaling pathway and receptor for thymosin beta 4

RegeneRx Biopharmaceuticals, Inc. nnounced that scientists have identified a long sought-after extracellular signaling pathway and receptor for thymosin beta 4 (Tβ4). The observation that Tβ4 increases cell surface ATP (energy produced by cells), could explain its ability to protect and regenerate tissue after ischemic injury and hypoxia (oxygen deficiency).

30 Nov 2010

Opinions: Obama's Global Fund pledge; harm reduction in Iran; HIV prevention; African development

There are some encouraging signs in the epic battle against AIDS and HIV infections. But those bright spots dim considerably in the face of the fact that about 7,100 people a day become infected.

30 Nov 2010

FDA approves Inspire to begin STAR clinical trial to evaluate UAS therapy for OSA

Inspire Medical Systems, a leading developer of neuro-stimulation therapies for the treatment of obstructive sleep apnea (OSA), announced today that the company has received approval from the U.S. Food and Drug Administration (FDA) to begin its STAR pivotal clinical trial. The STAR trial (Stimulation Therapy for Apnea Reduction), is a multi-center study that will evaluate both the safety and effectiveness of Inspire Upper Airway Stimulation (UAS) therapy in patients with moderate to severe obstructive sleep apnea (OSA).

30 Nov 2010

Are vitamin D and calcium supplements needed?

The IOM raised the recommended dietary allowance of vitamin D from the amount cited in their last report, released 13 years ago. It said that although 600 international units (IUs) of vitamin D or more each day is sufficient to maintain bone health in majority. But those aged 71 and older may need as much as 800 IUs daily, the IOM experts say. However 1997 recommendations advised 400 IUs per day for people aged 51 to 70 and 600 IUs per day for those over 70.

30 Nov 2010

HIV testing rates rise among Americans

A U.S. government report released Tuesday says that a record number of Americans are getting tested for HIV but more than 200,000 Americans are infected and are unaware of their status. In 2009 82.9 million adults age 18 to 64 had been tested for HIV. This is 11.4 million more than the total in 2006. Also until 2009 45 percent of adults had been tested at least once in their lives, up from 40 percent four years ago. However 55 percent of adults, and 28.3 percent of adults at risk for HIV, have never been tested, according to the report.

30 Nov 2010

Canadians at increased risk for flu complications not aware of all the facts

It starts with a headache, chills or that all-over-achy feeling. It comes on quickly, yet too many Canadians ignore the rapid onset of flu symptoms. But for the millions of Canadians at increased risk for developing serious complications from the flu, including people 65 and older, pregnant women and those with chronic medical conditions like chronic obstructive pulmonary disease (COPD), asthma, heart disease and diabetes, this 'laissez faire' attitude could be putting their health in jeopardy.

30 Nov 2010

Accelr8 extends technology evaluation agreement for BACcel rapid diagnostic system

Accelr8 Technology Corporation announced that it extended its technology evaluation agreement for its BACcel™ rapid diagnostic system with a global diagnostics company. The original agreement was announced on June 17, 2010. The essential terms remain unchanged and continue the funding to Accelr8 during the extended project period.

30 Nov 2010

Largest remote health monitoring project in the world launched in China

Canada-based IDEAL LIFE and China's Shandong NovaTech Biological Pharmaceutical Co., Ltd., a leading pharmaceutical manufacturer and medical products distribution network in China, announced the launch of the largest remote health monitoring project in the world, bringing wireless, remote health monitoring to the People's Republic of China.

30 Nov 2010

American Journal of Preventive Medicine delineates public health problem about caffeinated alcoholic beverages

In the wake of multiple state bans on caffeinated alcoholic beverages (CABs) and an FDA warning to four companies to remove their products from the marketplace, an article published online today in the American Journal of Preventive Medicine delineates the scope of the public health problem and suggests areas of research that might help address it.

30 Nov 2010

Total Immersion adds Vantage Surgical Systems to North American AR Partner network

Total Immersion, the global leader in augmented reality (AR), today announced the addition of Vantage Surgical Systems as a Certified D'Fusion Value Added Reseller to its North American Partner network, the world's largest network dedicated to AR.

30 Nov 2010

Group drumming can improve social, emotional behavior in low-income children: NAMM Foundation

The NAMM Foundation today announced the findings of a recent study that shows how group drumming can improve social and emotional behavior in low-income children.

30 Nov 2010

Super-sized World conference to address national health crisis of obesity

A conference at the New York Academy of Sciences on December 9 will convene leading obesity researchers to explore the latest science and policy initiatives addressing the global and national health crisis of obesity.

30 Nov 2010

Methodist to develop national training center for treatment of cardiovascular disease

The Methodist DeBakey Heart & Vascular Center recently received a generous gift to develop a national training center for surgical and interventional treatments for cardiovascular disease, the number one killer of Americans. The benefactor wishes to remain anonymous.

30 Nov 2010

Keryx announces positive top-line results from Zerenex Phase 3 study for hyperphosphatemia

Keryx Biopharmaceuticals, Inc. today announced positive top-line results from the Phase 3 short-term efficacy study component of its Phase 3 registration program of Zerenex (ferric citrate), the Company's ferric iron-based phosphate binder for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis.

30 Nov 2010

Increased staffing enhances patient survival in medical ICU

In a first-of-its-kind study to measure the impact of the highest recommended specialist staffing levels in an intensive care unit, researchers at the University of Maryland School of Medicine found that increased staffing by specially trained physicians and other health care professionals can enhance patient survival and enable patients to breathe sooner without assistance. The results of the study have been released online ahead of print in the journal Critical Care Medicine.

30 Nov 2010

University Hospitals receives $42 million for cancer care

Jane and Lee Seidman have donated $42 million to University Hospitals (UH) the largest gift in the Cleveland-based health system's history. In recognition of this unprecedented generosity, UH is naming the "Jane and Lee Seidman Cancer Center" in their honor.

30 Nov 2010

miRagen and t2cure enter licensing agreement for microRNA 92 technology

miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, and t2cure, a clinical stage biopharmaceutical company developing progenitor cell-based regenerative therapeutics for cardiac or peripheral vascular diseases, announced today that they have entered into a licensing agreement

30 Nov 2010

Medicine News and Research

New findings offer insights into novel treatment avenue for Crohn's Disease, sarcoidosis

Golimumab with methotrexate improves markers of inflammation and structural damage in RA patients

Celulas Genetica licenses new organ regeneration treatment from Chinese BBFITCL

Scientists identify signaling pathway and receptor for thymosin beta 4

Opinions: Obama's Global Fund pledge; harm reduction in Iran; HIV prevention; African development

FDA approves Inspire to begin STAR clinical trial to evaluate UAS therapy for OSA

Are vitamin D and calcium supplements needed?

HIV testing rates rise among Americans

Canadians at increased risk for flu complications not aware of all the facts

Accelr8 extends technology evaluation agreement for BACcel rapid diagnostic system

Largest remote health monitoring project in the world launched in China

American Journal of Preventive Medicine delineates public health problem about caffeinated alcoholic beverages

Total Immersion adds Vantage Surgical Systems to North American AR Partner network

Group drumming can improve social, emotional behavior in low-income children: NAMM Foundation

Super-sized World conference to address national health crisis of obesity

Methodist to develop national training center for treatment of cardiovascular disease

Keryx announces positive top-line results from Zerenex Phase 3 study for hyperphosphatemia

Increased staffing enhances patient survival in medical ICU

University Hospitals receives $42 million for cancer care

miRagen and t2cure enter licensing agreement for microRNA 92 technology

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News